Cue Health Receives Regulatory Approval in India for its Molecular, Point-of-Care COVID-19 Test

SAN DIEGO: SAN DIEGO, July 14, 2021 /PRNewswire/ — Cue Health Inc. ("Cue Health" or "Cue"), a healthcare technology company, today announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue COVID-19 Test for professional point-of-care use in India. Internationally, Cue has also received the CE mark in the European Union (EU), as well as Interim Order authorization from Health Canada.
Click here to view original post